Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring
Crossref DOI link: https://doi.org/10.1007/s00228-016-2083-4
Published Online: 2016-06-15
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Verbeeck, Roger K.
Günther, Gunar
Kibuule, Dan
Hunter, Christian
Rennie, Tim W.
License valid from 2016-06-15